Home
CLBT

CLBT

Cellebrite DI Ltd.

as of 12-05-2025 3:44pm EST

$18.10

$0.10

-0.55%

Stocks Technology Computer Software: Prepackaged Software Nasdaq

Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.

Chart Type:

Time Range:

Founded:	1999	Country:	Israel
Employees:	N/A	City:	N/A
Market Cap:	3.9B	IPO Year:	N/A
Target Price:	$24.40	AVG Volume (30 days):	1.4M
Analyst Decision:	Strong Buy	Number of Analysts:	5
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	0.31	EPS Growth:	N/A
52 Week Low/High:	$13.10 - $26.30	Next Earning Date:	11-12-2025
Revenue:	$455,903,000	Revenue Growth:	18.36%
Revenue Growth (this year):	20.21%	Revenue Growth (next year):	16.83%

AI-Powered CLBT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold

Model Accuracy: 71.70%

71.70%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full CLBT Forecast & Prediction with Hourly Data

Compare CLBT vs Leading Stocks

See how CLBT stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free CLBT Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "CLBT Cellebrite DI Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.